tiprankstipranks
Trending News
More News >
Alvotech (ALVO)
:ALVO
US Market
Advertisement

Alvotech (ALVO) Earnings Dates, Call Summary & Reports

Compare
232 Followers

Earnings Data

Report Date
Apr 01, 2026
After Close (Confirmed)
Period Ending
2026 (Q4)
Consensus EPS Forecast
-0.13
Last Year’s EPS
0.35
Same Quarter Last Year
Moderate Buy
Based on 3 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 12, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
The earnings call reflects a company with strong growth and strategic investments, but it is facing significant regulatory and operational challenges that have impacted its short-term financial outlook.
Company Guidance
During the Alvotech Q3 2025 Earnings Conference Call, the company outlined its financial guidance for the year and discussed several key metrics. The company has revised its full-year revenue guidance to a range of $570 million to $600 million and anticipates an adjusted EBITDA of $130 million to $150 million. This revision reflects the impact of a complete response letter (CRL) from the FDA, which caused a temporary disruption in production, and the shift of some licensing agreements for pipeline assets to 2026. Despite these challenges, the company continues to see strong global demand for its biosimilar products, with a projected compounded average growth rate (CAGR) of 94% from 2021 to the end of 2025. Alvotech has also emphasized its strategic focus on pipeline expansion and global launches, aiming to deliver sustained revenue and EBITDA growth in 2026.
Strong Revenue Growth
Alvotech reported a 420% revenue growth in 2024 and is guiding approximately 20% growth for 2025. The company has experienced an average annual growth rate of 127% from 2021 to 2024 and is projecting a compounded average growth rate of 94% through 2025.
Expanding Global Market Presence
Alvotech has launched its biosimilars in the U.S., Japan, and the U.K., and expects EMA approval soon for its biosimilar to Simponi. The company continues to hold significant market shares in Europe and Canada.
Pipeline and Product Approvals
The company has 5 approved biosimilars and 12 other disclosed development programs, with cell lines for an additional 15 targets. They are targeting a market worth over $185 billion.
Strategic Investments and Acquisitions
Alvotech has invested approximately $2 billion in building a global biosimilar company and recently acquired Ivers-Lee to increase capacity for finished product assembly and packaging.

Alvotech (ALVO) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

ALVO Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Apr 01, 2026
2026 (Q4)
-0.13 / -
0.35
Nov 12, 2025
2025 (Q3)
-0.03 / -0.10
-0.03-233.33% (-0.07)
Aug 13, 2025
2025 (Q2)
-0.05 / 0.03
0.14-78.57% (-0.11)
May 07, 2025
2025 (Q1)
-0.11 / 0.35
-0.89139.33% (+1.24)
Mar 26, 2025
2025 (Q4)
>-0.01 / -
-0.8
Nov 13, 2024
2024 (Q3)
-0.06 / -0.03
-0.5894.83% (+0.55)
Aug 15, 2024
2024 (Q2)
<0.01 / 0.14
-0.06333.33% (+0.20)
May 21, 2024
2024 (Q1)
-0.08 / -0.89
-1.2428.23% (+0.35)
Mar 26, 2024
2024 (Q4)
- / -
-1.289
Mar 20, 2024
2023 (Q4)
0.04 / -0.80
-1.28937.94% (+0.49)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

ALVO Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 12, 2025
$5.60$5.52-1.43%
Aug 13, 2025
$8.96$8.48-5.36%
May 07, 2025
$7.94$9.38+18.14%
Mar 26, 2025
$11.55$10.36-10.30%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Alvotech (ALVO) report earnings?
Alvotech (ALVO) is schdueled to report earning on Apr 01, 2026, After Close (Confirmed).
    What is Alvotech (ALVO) earnings time?
    Alvotech (ALVO) earnings time is at Apr 01, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is ALVO EPS forecast?
          ALVO EPS forecast for the fiscal quarter 2026 (Q4) is -0.13.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis